HHS ends FDA Unapproved Drugs Initiative, seeks to limit which drugs require FDA approval

• Published date: 02 December 2020
• Subject Matter: FDA,Prescription Drugs,Regulatory Reform,FDA Approval,Pharmaceutical Industry,Trump Administration,De Facto Injury,Department of Health and Human Services (HHS),Biden Administration
• Author: Robert Church,David Horowitz,Philip Katz
• Law Firm: Hogan Lovells